WHO validates China s Convidecia as 11th vaccine for COVID-19 – Latest News – The Nation nation.com.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nation.com.pk Daily Mail and Mail on Sunday newspapers.
CONVIDECIA is the 11th COVID-19 vaccine added to the growing portfolio of vaccines validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2.
GENEVA, May 19 (Xinhua) The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinopec having been certified by WHO Emergency Use Listing (EUL).
(Anadolu photo) GENEVA - The World Health Organization on Thursday approved Convidecia, a vaccine manufactured by China's CanSino Biologics, as the 11th approved vaccine to prevent the spread of Covid-19. In a statement, the UN health agency said Convidecia was assessed under its emergency use listing procedure, based on the review of data on quality, safety, efficacy, a risk management plan, programmatic suitability and a manufacturing site inspection. "The Technical Advisory Group for Emergency Use Listing, convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets the WHO standards for protection against Covid-19 and that the benefits of the vaccine far outweigh risks," the press release said. It added that the single-dose vaccine was also reviewed by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), which has recommended its use in all age groups 18 and above. "Convidecia was found to have 64